Himax Technologies stock has more than doubled over the past three years, yet the broader valuation checks suggest it no longer stands out as a clear bargain, even as recent news around its new AI vision and robotics products keeps growth hopes in focus.

• Himax Technologies has delivered a 107.4% return over the last three years, which puts extra attention on whether the current price already reflects much of that progress.
• The launch of its HE Series iToF depth decoder ICs for AI vision and robotics can support expectations for future demand. The key risk is that adoption or monetisation of these products may fall short of what is implied in the current share price.
• With a value score of 1 out of 6, Himax Technologies screens as leaning expensive rather than an obvious value opportunity on the broader set of valuation checks.

The issue now is whether Himax Technologies' recent gains and product momentum leave enough valuation upside to compensate for the risks investors are taking on.

Does Himax Technologies Look Fairly Valued on Earnings?

The P/E ratio is a useful yardstick for Himax Technologies because earnings are a key focus for many semiconductor investors. Himax currently trades on a P/E of about 72.5x, which is higher than the peer group average of 30.0x and above the broader semiconductor industry average of 59.8x. On simple comparisons, the stock carries a clear premium to both its direct peers and the wider sector.

However, a more tailored fair multiple that considers Himax Technologies' profile points to a P/E of around 79.5x. This is not far from where the stock sits today. Despite the recent HE Series iToF launch keeping attention on its AI vision and robotics angle, the current valuation already aligns quite closely with what this framework suggests as appropriate.

Overall, Himax Technologies looks roughly fairly valued on its P/E multiple relative to its tailored fair ratio benchmark.

The Himax Technologies Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation work on Himax Technologies leaves off. They spell out which paths for growth, margins and earnings would need to play out for the stock to look meaningfully stronger or weaker than today, using a set of scenarios on the Community page. Each one links its number to a clear view on how Himax Technologies' growth, profitability and risk profile could evolve, so you can compare and revisit those views as fresh information comes through.

One of the top community narratives on Himax Technologies: 56% undervalued

"Himax's unique leadership in smart glasses offering all three critical enabling technologies, ultra low power sensing, microdisplay, and nano optics, makes it a prime beneficiary as AI driven AR wearables achieve mass consumer adoption…"

Do you think there's more to the story for Himax Technologies? Head over to our Community to see what others are saying!

The Bottom Line

For Himax Technologies, the key takeaway is that the stock now looks about right on the main market multiple checks rather than clearly cheap. The current P/E sits close to the tailored fair multiple, so future returns are more likely to hinge on how well the business delivers against the expectations already embedded in that premium. The crux for both bulls and bears is whether Himax Technologies can turn interest in its AI vision and robotics offerings into durable earnings, at a level that justifies keeping the valuation where it is or improving it.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.